STOCK TITAN
  1. Home
  2. Sec-filings
  3. NGENF
  4. [CERT] NERVGEN PHARMA CORP. Certification Filing

[CERT] NERVGEN PHARMA CORP. Certification Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
CERT

Rhea-AI Filing Summary

Analyzing...
CERT - NERVGEN PHARMA CORP.

CERT Filing - NERVGEN PHARMA CORP.

This filing is available as a PDF document.

Filing Type: CERT

Company: NERVGEN PHARMA CORP. (NGENF)

Acceptance Date: 2026-01-07T17:03:43.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock NGENF logo
Nervgen Pharma Corp

OTC:NGENF

NGENF Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

NGENF Latest News

Feb 11, 2026
NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium
Feb 9, 2026
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
Jan 20, 2026
NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing
Jan 8, 2026
NervGen Pharma Begins Trading on Nasdaq Today
Dec 17, 2025
NervGen Pharma Announces Filing of Form F-10 Registration Statement with The SEC Under MJDS

NGENF Latest SEC Filings

Feb 13, 2026
[6-K] NERVGEN PHARMA CORP. Current Report (Foreign Issuer)
Feb 13, 2026
[6-K] NERVGEN PHARMA CORP. Current Report (Foreign Issuer)
Feb 10, 2026
[6-K] NERVGEN PHARMA CORP. Current Report (Foreign Issuer)
Feb 10, 2026
[6-K] NERVGEN PHARMA CORP. Current Report (Foreign Issuer)
Jan 8, 2026
[6-K] NERVGEN PHARMA CORP. Current Report (Foreign Issuer)

NGENF Stock Data

194.18M
60.94M
Biotechnology
Healthcare
Link
Canada
Vancouver